Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOCICLIB Cause Incorrect dose administered? 171 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Incorrect dose administered have been filed in association with RIBOCICLIB (KISQALI). This represents 0.6% of all adverse event reports for RIBOCICLIB.

171
Reports of Incorrect dose administered with RIBOCICLIB
0.6%
of all RIBOCICLIB reports
23
Deaths
44
Hospitalizations

How Dangerous Is Incorrect dose administered From RIBOCICLIB?

Of the 171 reports, 23 (13.5%) resulted in death, 44 (25.7%) required hospitalization, and 10 (5.8%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 171 reports have been filed with the FAERS database.

What Other Side Effects Does RIBOCICLIB Cause?

Neutropenia (3,585) Nausea (3,404) Fatigue (3,327) Malignant neoplasm progression (2,468) Death (2,452) Vomiting (1,953) Diarrhoea (1,830) White blood cell count decreased (1,683) Pain (1,637) Metastases to bone (1,538)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which RIBOCICLIB Alternatives Have Lower Incorrect dose administered Risk?

RIBOCICLIB vs RIBOFLAVIN RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE RIBOCICLIB vs RIFABUTIN RIBOCICLIB vs RIFAMPICIN

Related Pages

RIBOCICLIB Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered RIBOCICLIB Demographics